Document Detail


Flow cytometric analysis of circulating microparticles in plasma.
MedLine Citation:
PMID:  20235276     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Microparticles, which include exosomes, micro-vesicles, apoptotic bodies and apoptotic microparticles, are small (0.05 - 3 mum in diameter), membranous vesicles that can contain DNA, RNA, miRNA, intracellular proteins and express extracellular surface markers from the parental cells. They can be secreted from intracellular multivesicular bodies or released from the surface of blebbing membranes. Circulating microparticles are abundant in the plasma of normal individuals and can be derived from circulating blood cells such as platelets, red blood cells and leukocytes as well as from tissue sources, such as endothelial and placental tissues. Elevated levels of microparticles are associated with various diseases such as thrombosis (platelet microparticles), congestive heart failure (endothelial microparticles), breast cancer patients (leukocyte microparticles) and women with preeclampsia (syncytiotrophoblast microparticles). Although microparticles can be detected by microscopy, enzyme-linked immunoassays and functional assays, flow cytometry is the preferred method because of the ability to quantitate (fluorescent bead- or flow rate-based method) and because of polychromatic capabilities. However, standardization of pre-analytical and analytical modus operandi for isolating, enumerating and fluorescent labeling of microparticles remains a challenge. The primary focus of this article is to review the preliminary steps required to optimally study circulating in vivo microparticles which include: 1) centrifugation speed used, 2) quantitation of microparticles before antibody labeling, 3) levels of fluorescence intensity of antibody-labeled microparticles, 4) polychromatic flow cytometric analysis of microparticle sub-populations and 5) use of polyclonal antibodies designed for Western blotting for flow cytometry. These studies determine a roadmap to develop microparticles as biomarkers for a variety of conditions.
Authors:
Aaron F Orozco; Dorothy E Lewis
Related Documents :
7496966 - A comparative study of frozen-section immunoperoxidase and flow cytometry for immunophe...
12499226 - Flow cytometric assessment of susceptibilities of streptococcus pyogenes to erythromyci...
6466256 - Use of impedance plethysmography to continually monitor bone marrow blood flow.
3366226 - Liver involvement at diagnosis of primary myelofibrosis: a clinicopathological study of...
11542226 - Anatomical and gravitational influences on cardiac displacement in snakes (lepidosauria...
14672566 - Oscillometric assessment of airway obstruction in a mechanical model of vocal cord dysf...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Review    
Journal Detail:
Title:  Cytometry. Part A : the journal of the International Society for Analytical Cytology     Volume:  77     ISSN:  1552-4930     ISO Abbreviation:  Cytometry A     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-05-27     Completed Date:  2010-09-15     Revised Date:  2011-07-28    
Medline Journal Info:
Nlm Unique ID:  101235694     Medline TA:  Cytometry A     Country:  United States    
Other Details:
Languages:  eng     Pagination:  502-14     Citation Subset:  IM    
Copyright Information:
Copyright 2010 International Society for Advancement of Cytometry.
Affiliation:
University of Texas Health Science Center at Houston, Internal Medicine/Infectious Diseases, Houston, Texas 77030, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Chemical Analysis / methods*
Blotting, Western
Cell Line
Cell-Derived Microparticles / chemistry*
Flow Cytometry*
Fluorescence
Humans
Staining and Labeling
Grant Support
ID/Acronym/Agency:
HDO46623//PHS HHS; R01 HD046623-03/HD/NICHD NIH HHS; T32AI007495/AI/NIAID NIH HHS
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Meso-Substituted Liquid Porphyrins.
Next Document:  (R)-(+)-Binol-Functionalized Mesoporous Organosilica as a Highly Efficient Pre-Chiral Catalyst for A...